Correlation Between LivaNova PLC and CONMED
Can any of the company-specific risk be diversified away by investing in both LivaNova PLC and CONMED at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LivaNova PLC and CONMED into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LivaNova PLC and CONMED, you can compare the effects of market volatilities on LivaNova PLC and CONMED and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LivaNova PLC with a short position of CONMED. Check out your portfolio center. Please also check ongoing floating volatility patterns of LivaNova PLC and CONMED.
Diversification Opportunities for LivaNova PLC and CONMED
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between LivaNova and CONMED is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding LivaNova PLC and CONMED in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CONMED and LivaNova PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LivaNova PLC are associated (or correlated) with CONMED. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CONMED has no effect on the direction of LivaNova PLC i.e., LivaNova PLC and CONMED go up and down completely randomly.
Pair Corralation between LivaNova PLC and CONMED
Given the investment horizon of 90 days LivaNova PLC is expected to generate 1.18 times more return on investment than CONMED. However, LivaNova PLC is 1.18 times more volatile than CONMED. It trades about -0.08 of its potential returns per unit of risk. CONMED is currently generating about -0.1 per unit of risk. If you would invest 4,570 in LivaNova PLC on December 29, 2024 and sell it today you would lose (657.00) from holding LivaNova PLC or give up 14.38% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
LivaNova PLC vs. CONMED
Performance |
Timeline |
LivaNova PLC |
CONMED |
LivaNova PLC and CONMED Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with LivaNova PLC and CONMED
The main advantage of trading using opposite LivaNova PLC and CONMED positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LivaNova PLC position performs unexpectedly, CONMED can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CONMED will offset losses from the drop in CONMED's long position.LivaNova PLC vs. Orthopediatrics Corp | LivaNova PLC vs. Pulmonx Corp | LivaNova PLC vs. Si Bone | LivaNova PLC vs. Neuropace |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |